Projects per year
Search results
-
Active
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
Betts, B., Holtan, S. G. & Linden, M. A.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
4/1/23 → 2/29/28
Project: Research project
-
PTCy + Sirolimus/VIC-1911 as GVHD prophylaxis in myeloablative PBSC transplantation
8/20/21 → 8/31/26
Project: Research project
-
AGAVE-201, A Phase 2, Open-label, Randomized, MulticenterStudy to Evaluate the Efficacy, Safety and Tolerability ofAxatilimab at 3 Different Doses in Patients with Recurrent orRefractory Active Chronic Graft Versus Host Disease who haveReceived at le
Holtan, S. G. & Arora, M.
11/1/20 → 10/31/25
Project: Research project
-
Neoadjuvant therapy for patients with high risk stage III melanoma
Domingo-Musibay, E. & Holtan, S. G.
MAYO CLINIC ROCHESTER, AMERICAN ASSOCIATION FOR CANCER RESEARCH
6/1/18 → 11/30/24
Project: Research project
-
ALT-803 (IL-15/IL-15Ra-Fc) maintenance after allogeneic
Holtan, S. G., Arora, M., Wagner, J. E., Brunstein, C. G. & Weisdorf, D. J.
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
7/26/17 → 6/30/24
Project: Research project
-
ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
Holtan, S. G., Brunstein, C. G. & Weisdorf, D. J.
National Heart, Lung, and Blood Institute
7/26/17 → 6/30/24
Project: Research project
-
Finished
-
MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
5/1/20 → 11/30/21
Project: Research project
-
MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalablestepped care self-management program for survivors after hematopoietic cell transplantation
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
5/1/19 → 4/30/20
Project: Research project
-
-
A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of SNDX-6352 in Subjects with Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Prior Therapy, i
Holtan, S. G. & Arora, M.
9/1/18 → 2/28/24
Project: Research project
-
-
-
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY
12/1/17 → 12/31/23
Project: Research project
-
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
9/21/17 → 8/31/19
Project: Research project
-
A Phase 1 Study of the Clinical and Immunologic
FRED HUTCHINSON CANCER CENTER, ALTOR BIOSCIENCE LLC
7/1/16 → 12/31/19
Project: Research project
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
FRED HUTCHINSON CANCER CENTER, MELANOMA RESEARCH ALLIANCE
9/1/15 → 12/30/18
Project: Research project
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/15 → 8/31/17
Project: Research project
-
13 SCP - Randomized Study of Individualized Care Plans f
NATIONAL MARROW DONOR PROGRAM, PATIENT-CENTERED OUTCOMES RESEARCH INST.
6/24/15 → 12/31/16
Project: Research project
-
-
-
-
-
PROCLAIM: Proleukin Obervational Registry to Evaluate
Holtan, S. G., Dudek, A. Z. & Rudrapatna, V. K.
10/1/11 → 12/31/19
Project: Research project